Israel vs Oceania (exc. Australia and New Zealand): Proportion of the target population who received a 3rd dose of
Israel
94.0%
in 2024
Oceania (exc. Australia and New Zealand)
50.0%
in 2024
Israel rank
36th
Oceania (exc. Australia and New Zealand) rank
33rd
Proportion of the target population who received a 3rd dose of over time
- Israel
- Oceania (exc. Australia and New Zealand)
How they compare
Israel currently reports 94.0% against 50.0% in Oceania (exc. Australia and New Zealand), a difference of 44.0%.
That makes Israel's figure about 1.9 times Oceania (exc. Australia and New Zealand)'s.
Across all 14 years both countries report, Israel has been ahead every year.
Israel ranks 36th and Oceania (exc. Australia and New Zealand) ranks 33rd of 157 countries.
Israel has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Israel | Oceania (exc. Australia and New Zealand) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 93.8% | 21.7% | 72.1% | Israel |
| 2020s | 94.2% | 44.8% | 49.4% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Israel or Oceania (exc. Australia and New Zealand)?
- Israel, at 94.0% against 50.0% in Oceania (exc. Australia and New Zealand) as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Israel and Oceania (exc. Australia and New Zealand)?
- 44.0%, with Israel ahead.
- How many years of comparable data are there for Israel and Oceania (exc. Australia and New Zealand)?
- 14 years are reported by both, from 2011 to 2024.
- How do Israel and Oceania (exc. Australia and New Zealand) rank globally for proportion of the target population who received a 3rd dose of?
- Israel ranks 36th and Oceania (exc. Australia and New Zealand) ranks 33rd of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.